Recombinant Vaccines Market Forecast to Reach USD 30.6 Billion by 2030, Driven by Ongoing Technical Enhancements in Vaccine Production and Delivery

Mordor Intelligence has published a new report on recombinant vaccines market offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction

The recombinant vaccines market size stands at USD 18.3 billion in 2025 and is projected to reach USD 30.6 billion by 2030, reflecting an 11.1% CAGR over the forecast period, driven by steady demand across key disease areas and ongoing technical enhancements in vaccine production and delivery. This forecast reflects the increasing adoption of recombinant technology platforms, broader implementation of vaccine programs, and strong participation from both established and emerging market players in driving market expansion. The recombinant vaccines market size is supported by heightened global health initiatives, greater funding for rapid vaccine scalability, and evolving market dynamics that increase uptake and broader immunization coverage worldwide.

Report Overview:

https://www.mordorintelligence.com/industry-reports/recombinant-vaccines-market?utm_source=openpr

Key Trends

Strengthening Vaccine Mandates:
Increasing HPV immunization mandates and adult catch-up vaccination policies are supporting stable demand and reinforcing long-term market growth.

Boost in Manufacturing Readiness:
Expanded funding for rapid-scale production capabilities is improving manufacturing momentum and ensuring stronger preparedness for emerging infectious diseases.

Rise of Next-Generation Platforms:
Advanced technologies such as mRNA and VLP-based vaccines are gaining market traction, diversifying product pipelines, and accelerating innovation alongside traditional protein subunit vaccines.

Advances in Expression Systems:
Improvements in yeast and plant-based expression platforms are helping reduce production costs, enhance efficiency, and strengthen supply chain resilience across global immunization programs.

Market Segmentation

The recombinant vaccines market analysis includes several key segmentation categories that reveal how the market distributes demand and opportunities across different criteria

By Technology Type

Protein Subunit Vaccines

Virus-Like Particle (VLP) Vaccines

Viral Vector - Replicating

Viral Vector - Non-replicating

DNA Plasmid Vaccines

mRNA Vaccines

By Disease Indication

Human Papillomavirus (HPV)

Hepatitis B

Influenza

Shingles (Herpes Zoster)

Dengue

Malaria

Respiratory Syncytial Virus (RSV)

COVID-19

Oncology (Therapeutic Vaccines)

By Expression Platform

Yeast (Pichia, Saccharomyces)

Bacterial (E. coli)

Insect Cell (Baculovirus)

Mammalian Cell (CHO, HEK)

Plant-based

Cell-Free Synthetic

By End User

Pediatric

Adolescent & Adult

Geriatric

By Route of Administration

Intramuscular Injection

Subcutaneous Injection

Intradermal Injection

Oral

Others

By Geography

North America

Europe

Asia-Pacific

Middle East & Africa

South America

This segmentation insights into the recombinant vaccines market not only clarify demand distribution but also help stakeholders understand where future investment and development may be most impactful.

Key Players

The recombinant vaccines market share remains concentrated among a group of established vaccine manufacturers with a strong presence in both global and regional markets. Key players include major pharmaceutical companies that have extensive research and development infrastructure, broad product portfolios, and well-established manufacturing capabilities. These participants hold a significant portion of total revenue and contribute to market competitiveness.

Merck & Co.

GlaxoSmithKline plc

Pfizer Inc.

Sanofi

Moderna Inc.

Conclusion:

The outlook for the recombinant vaccines market remains positive, with robust growth expected across multiple segments as global health priorities continue to emphasize vaccine accessibility and coverage. Sustained public health commitments, rising investments in modern vaccine technologies, and increasing adoption of advanced expression platforms underscore anticipated market performance. The recombinant vaccines market analysis indicates that diversified approaches to vaccine development, production, and administration will support long-term expansion and reinforce the role of recombinant vaccines in preventing infectious diseases across populations.

For complete market analysis, please visit the Mordor Intelligence page:

https://www.mordorintelligence.com/industry-reports/recombinant-vaccines-market?utm_source=openpr

Industry related Reports:

Preventive Vaccines Market : The Preventive Vaccines Market segments the industry into By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines, Other Vaccine Types), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps, and Rubella (MMR), COVID-19, Other Disease Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).


Get more Insights: https://www.mordorintelligence.com/industry-reports/preventive-vaccines-market?utm_source=openpr

Viral Vaccines Market: The Viral Vaccines Market is Segmented by Form (Liquid Vaccines and Lyophilized Vaccines), Type (Live-Attenuated, Inactivated, and More), Approach (Therapeutic and Preventive), Age Group (Pediatric, Adult, and Geriatric), Distribution Channel (Public and Private) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

Get more Insights: https://www.mordorintelligence.com/industry-reports/viral-vaccines-market?utm_source=openpr

Vaccines Market:

The Vaccines Market report segments the industry into By Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, mRNA Vaccines, Recombinant Vaccines, Toxoid Vaccines, and more), By Type (Monovalent Vaccines, Multivalent Vaccines), By Disease Indication (DTP, Hepatitis, Herpes Zoster, HPV, Influenza, and more), By Route of Administration (Oral Administration, and more), By End-User, and By Geography.

Get more Insights: https://www.mordorintelligence.com/industry-reports/vaccines-market?utm_source=openpr





About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.